E-LIB Suche - Ergebnisse für: Bethge, Wolfgang

1

Long-term outcome after allogeneic hematopoietic cell trans..:

Robin, Marie ; De Wreede, Liesbeth C ; Wolschke, Christine...
10.3324/haematol.2018.205211. , 2024

Link: https://hdl.handle.net/2..

2

CD19-Targeting CAR T Cells for Myositis and Interstitial Lu..:

Pecher, Ann-Christin ; Hensen, Luca ; Klein, Reinhild...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300719/. , 2023

Link: http://www.ncbi.nlm.nih...

3

P1398: AXICABTAGENE CILOLEUCEL VERSUS TISAGENLECLEUCEL CAR-..:

Gagelmann, Nico ; Bishop, Michael ; Dreger, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430492/. , 2023

Link: http://www.ncbi.nlm.nih...

4

A multicenter prospective, randomized, placebo-controlled p..:

Weissinger, Eva M ; Metzger, Jochen ; Schleuning, Michael...
https://www.nature.com/articles/s41375-020-01059-3#Sec16. , 2023

Link: https://doi.org/10.18725..

5

P1278: MEASURABLE RESIDUAL DISEASE ASSESSMENT IN THE PROSPE..:

Arnhardt, Isabell ; Kloos, Arnold ; Kattre, Nadine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430507/. , 2023

Link: http://www.ncbi.nlm.nih...

6

PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DE..:

Borst, Carla ; Ginsberg, Franziska ; Weller, Jan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430234/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Phase I study evaluating the Fc-optimized FLT3 antibody FLY..:

Heitmann, Jonas S ; Schlenk, Richard F ; Dörfel, Daniela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433561/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditio..:

Bug, Gesine ; Labopin, Myriam ; Niittyvuopio, Riitta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247361/. , 2023

Link: http://www.ncbi.nlm.nih...

9

P1268: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HI..:

Christian Schröder, Jan ; Faustmann, Philipp ; Frederic Weller, Jan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430713/. , 2023

Link: http://www.ncbi.nlm.nih...

10

RNA therapeutics for improving CAR T cell safety and effica..:

Schaible, Philipp ; Bethge, Wolfgang ; Lengerke, Claudia.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614194/. , 2023

Link: http://www.ncbi.nlm.nih...

11

P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOUR..:

Haupt, Maik ; Jäkel, Nadja ; Wachsmuth, Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428411/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Total body irradiation versus busulfan based intermediate i..:

Hirschbühl, Klaus ; Labopin, Myriam ; Polge, Emmanuelle...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/106366. , 2023

Link: https://opus.bibliothek...

13

Reduced 8-Gray compared to standard 12-Gray Total Body Irra..:

Spyridonidis, Alexandros ; Labopin, Myriam ; Savani, Bipin...
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/103303. , 2023

Link: https://opus.bibliothek...

14

Real-world results of CAR T-cell therapy for large B-cell l..:

Ayuk, Francis ; Gagelmann, Nico ; von Tresckow, Bastian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506090/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Outcomes of axicabtagene ciloleucel in PMBCL compare favora..:

Schubert, Maria-Luisa ; Bethge, Wolfgang ; Ayuk, Francis...
https://freidok.uni-freiburg.de/data/238859. , 2023

Link: https://freidok.uni-frei..